Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Interest & Investment Income of $3.6 million for Q1 2026, down 2.34% year-over-year from $3.6 million in Q1 2025, and down 13.0% quarter-over-quarter from $4.1 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Interest & Investment Income data on file, last reported at $3.6 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $3.6 million, down 2.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.2 million (down 0.63% YoY), and the FY2025 annual result was $15.3 million, up 3.96% from the prior year.
- Interest & Investment Income slipped to $3.6 million in Q1 2026 per RYTM's latest filing, from $4.1 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $4.3 million in Q3 2025 and troughed at $160000.0 in Q1 2022.
- A 5-year average of $3.1 million and a median of $3.5 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 2169.4% in 2022, then dropped 20.87% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $3.0 million in 2022, then advanced by 25.58% to $3.8 million in 2023, then declined by 7.96% to $3.5 million in 2024, then grew by 16.22% to $4.1 million in 2025, then retreated by 13.0% to $3.6 million in 2026.
- Business Quant data shows RYTM's Interest & Investment Income at $3.6 million in Q1 2026, $4.1 million in Q4 2025, and $4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.33 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 920,000.00 |
| Jun 30, 2022 | 274,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 21,000.00 |